Overview
Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 months old) who are at high risk for autism, particularly those from diverse cultural and language backgrounds.
What Will Happen: Researchers will compare two versions of the Pathways Intervention:
- Version 1: Includes mutual gaze strategies.
- Version 2: Does not include mutual gaze strategies.
What to Expect: Participants will:
- Attend 12 sessions of Pathways Intervention, each lasting 1.5 hours (or 15 weeks if there are cancellations).
- Come to the clinic for a developmental check-up three times: before starting Pathways, right after completing Pathways, and three months after finishing Pathways.
Description
Purpose of the Study: The primary goal of this clinical trial is to evaluate whether a parent-mediated treatment can improve social communication, language, and adaptive functioning in 16-30-month-old children from diverse cultural and language backgrounds who are at high risk for autism (referred to as children with social challenges).
Study Design:
- Study Phase: N/A
- Intervention Model: Participants are assigned to one of two groups in parallel.
Study Description:
- Participants: 80 children aged 16-30 months who show social communication challenges
and are at high risk for autism will be randomly assigned to one of two groups:
- Group 1: Pathways Intervention with mutual gaze strategies.
- Group 2: Pathways Intervention without mutual gaze strategies.
- Intervention Sessions: Participants will attend 12 sessions, each lasting 1.5 hours, over approximately 15 weeks (allowing for possible cancellations) of parent-mediated intervention in their homes or another convenient location.
Assessments: To track progress and evaluate long-term effects, participants will undergo several culturally and linguistically appropriate assessments at three time points:
- Baseline: Within two weeks before starting the intervention.
- Post-Intervention: Within two weeks after completing the intervention.
- Three-Month Follow-Up: 12-15 weeks after completing the intervention.
Each evaluation will take around two hours and will include:
- Child Assessments:
- Mullen Scale of Early Learning (MSEL): Assesses general developmental age (administered only at baseline).
- Communication and Symbolic Behavior Scales-Developmental Profile (CSBS-DP): Evaluates social communication.
- EarliPointTM: Measures social, verbal, and nonverbal cognition.
- Caregiver Questionnaires:
- Vineland Adaptive Behavior Scales, Third Edition (VABS-III): Assesses adaptive functioning.
- PhenX Toolkit Core Measures: Collects family and child demographic information, including parents' and grandparents' place of birth (administered only at baseline).
The CSBS-DP and VABS-III have been validated as appropriate measures for determining meaningful changes in children with or at high risk for autism, based on previous research
Eligibility
Inclusion Criteria:
- Children must be between 16-30 months old at the start of the study;
- Children must receive social disability index of 7 or lower on the EarliPointTM assessment with a researcher (i.e., human) confirming social challenges are present;
- Parents must report no other known neurological or genetic concerns or disorders
- Parents must be fluent in English
- Parents must live within a 30-mile radius of the Callier Center Dallas.
Exclusion Criteria:
- Children younger than 16 months or older than 30 months at the start of the study
- Children who are not at high risk for autism based on an EarliPointTM assessment (with researcher confirmation of social challenges)
- Children whose parents report they have any other known neurological or genetic concerns or disorders;
- Children whose parents are not fluent in English.